CD4 and neoplasm: Indeed, in 2013, an article illustrated how tumor-derived B16 pericyte upregulated co-stimulatory molecules (CD80 and CD86), the co-inhibitory molecule (PD-L1), and MHC-II, which directly downregulate CD4+ T-cell proliferation and IL-4 and IFN-γ secretion.